These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36172093)

  • 1. Phospholipase A2 receptor is associated with hypercoagulable status in membranous nephropathy: a narrative review.
    Lu X; Kan C; Zhang R
    Ann Transl Med; 2022 Sep; 10(17):938. PubMed ID: 36172093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor.
    Pan Y; Wan J; Liu Y; Yang Q; Liang W; Singhal PC; Saleem MA; Ding G
    Sci Rep; 2014 Oct; 4():6660. PubMed ID: 25335547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population.
    Ardalan M; Ghafari A; Hamzavi F; Nasri H; Baradaran B; Majidi J; Nikbin B
    J Nephropathol; 2013 Oct; 2(4):241-8. PubMed ID: 24475456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK/mTOR/ULK1
    Yang L; Wu Y; Lin S; Dai B; Chen H; Tao X; Li G; Wan J; Pan Y
    FASEB J; 2021 Feb; 35(2):e21170. PubMed ID: 33184968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum secretory phospholipase A2 group IB correlates with the severity of membranous nephropathy.
    Li W; Zhang M; Guo Y; Liu X; Ji X; Su J; Zhang Z; Zhang F
    Clin Chim Acta; 2018 Jul; 482():178-184. PubMed ID: 29649452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
    Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
    Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy.
    Jo HA; Hyeon JS; Yang SH; Jung Y; Ha H; Jeong CW; Kwak C; Kim Y; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Hwang GS; Kim DK
    Kidney Int; 2021 Feb; 99(2):443-455. PubMed ID: 32712166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
    Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
    Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.
    Ruggenenti P; Debiec H; Ruggiero B; Chianca A; Pellé T; Gaspari F; Suardi F; Gagliardini E; Orisio S; Benigni A; Ronco P; Remuzzi G
    J Am Soc Nephrol; 2015 Oct; 26(10):2545-58. PubMed ID: 25804280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of Anti-Phospholipase A2 and Anti-Thrombospondin Type 1 Domain-Containing Protein 7A in Latin Patients with Membranous Nephropathy.
    Battaini LC; Ranzani OT; Marçal LJ; Antonangelo L; Jorge LB; Bitencourt CD; Woronik V; Malheiros DMA; Yu L
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
    Morioka Y; Saiga A; Yokota Y; Suzuki N; Ikeda M; Ono T; Nakano K; Fujii N; Ishizaki J; Arita H; Hanasaki K
    Arch Biochem Biophys; 2000 Sep; 381(1):31-42. PubMed ID: 11019817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2.
    Hanasaki K; Arita H
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():71-82. PubMed ID: 12432910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy.
    Song EJ; Jeong KH; Yang YA; Lim JH; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Kidney Res Clin Pract; 2018 Sep; 37(3):248-256. PubMed ID: 30254849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.
    Hoxha E; Thiele I; Zahner G; Panzer U; Harendza S; Stahl RA
    J Am Soc Nephrol; 2014 Jun; 25(6):1357-66. PubMed ID: 24610926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
    Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS
    J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway.
    Chiou TT; Chau YY; Chen JB; Hsu HH; Hung SP; Lee WC
    Biomed Pharmacother; 2021 Dec; 144():112349. PubMed ID: 34700229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-phospholipase A2 receptor antibodies directly induced podocyte damage
    Li Y; Yu J; Wang M; Cui Z; Zhao MH
    Ren Fail; 2022 Dec; 44(1):304-313. PubMed ID: 35333675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy.
    Wen J; Xie K; Zhang M; Chen J; Zhang J; Cheng D; Li X; Ji S; Liu Z
    Medicine (Baltimore); 2016 Sep; 95(37):e4809. PubMed ID: 27631233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A
    Iio R; Akiyama S; Mitsumoto K; Iwata Y; Okushima H; Shimada K; Ota N; Tomida K; Fushimi H; Shoji T; Matsumoto M; Hayashi T
    BMC Nephrol; 2020 Oct; 21(1):431. PubMed ID: 33046023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.